[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Monoclonal Antibodies In Veterinary Health Market Size, Share & Trends Analysis Report By Application (Dermatology, Pain), By Animal Type, By End-user, By Region, And Segment Forecasts, 2023 - 2030

July 2023 | 150 pages | ID: MFC95F00CF6AEN
Grand View Research, Inc.

US$ 5,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report can be delivered to the clients within 4 Business Days

Monoclonal Antibodies In Veterinary Health Market Growth & Trends

The global monoclonal antibodies in veterinary health market size is expected to reach USD 2.42 billion by 2030, expanding at a CAGR of 17.1% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing pet population coupled with the rising pet expenditure is expected to boost the market growth. Furthermore, the growing prevalence of canine atopic dermatitis will likely drive market growth over the forecast period.

Despite disruption due to the COVID-19 pandemic, the animal health industry witnessed a steady growth of 8% from 2019 to 2020. The economic downturn was relatively less impactful in the animal health industry compared to other markets. The pandemic created a few shifts in business models for veterinary practices and veterinarians. Traditional veterinary practices are expected to generate the most revenue from selling high-margin products like biologics and pharmaceuticals.

The growing incidences of cancer, especially in dogs, are anticipated to provide a growth platform for the market. According to the American Veterinary Medical Association (AVMA), around 1 out of every 4 dogs are expected to show signs of neoplasia at some point in their lives. Neoplasia is a common type of cancer in dogs. Pain management is one of the most important aspects of treating neoplasia in dogs. This can also be treated using the monoclonal antibody treatment.

The market is highly competitive and consists of several major players. With the emergence of immense opportunities in the market, various players in the market are making investments to emerge as leading players. For instance, in October 2021, Zoetis acquired a new development and manufacturing unit in Ireland to improve its production capabilities on veterinary Monoclonal Antibodies (mAbs).

This is anticipated to enhance its veterinary therapeutic biopharmaceuticals portfolio. Moreover, in August 2021, Elanco acquired Kindred Biosciences for approximately USD 444 million. This supported the company’s access to the dermatology market, complemented its product pipeline, and enhanced R&D capabilities in biologics and monoclonal antibodies.

In addition, in May 2023, Elanco announced its breakthrough treatment for deadly canine parvovirus diseases using monoclonal antibodies. This single intravenous dose treats the signs caused by parvovirus in sick dogs and puppies regardless of their vaccination status.

Monoclonal Antibodies In Veterinary Health Market Report Highlights
  • Based on animal type, the dog segment held the dominant revenue share in 2022 owing to the growing adoption of dogs as pets and increasing R&D targeting canine disease treatments
  • Based on the application, the dermatology segment accounted for the largest market share of over 50% in 2022, owing to the increasing prevalence of canine atopic dermatitis
  • The veterinary hospital segment accounted for a dominant market share in terms of end-user in 2022, owing to the availability of advanced treatment facilities in veterinary hospitals
  • The North America accounted for the largest market share of around 40% in 2022, owing to the presence of major market players in the region
CHAPTER 1. METHODOLOGY AND SCOPE

1.1. Market Segmentation and Scope
1.2. Research Methodology
  1.2.1. Information Procurement
1.3. Information or Data Analysis
1.4. General Methodology
1.5. Research Scope & Assumptions
1.6. Market Formulation & Validation
1.7. Model Details
  1.7.1. Commodity Flow Analysis
  1.7.2. Bottom-Up & Hybrid Model
  1.7.3. CAGR Calculation
1.8. List of Secondary Sources

CHAPTER 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

CHAPTER 3. MARKET VARIABLES, TRENDS, & SCOPE

3.1. Market Lineage Outlook
  3.1.1. Parent Market Outlook
  3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
  3.2.1. Market Driver Analysis
  3.2.2. Market Restraint Analysis
  3.2.3. Market Opportunity Analysis
  3.2.4. Market Challenge Analysis
3.3. Industry Analysis
  3.3.1. Porter’s
  3.3.2. PESTEL
3.4. Regulatory Framework
3.5. Product Pipeline Analysis
3.6. COVID-19 Impact Analysis

CHAPTER 4. MONOCLONAL ANTIBODIES IN VETERINARY HEALTH MARKET: ANIMAL TYPE ESTIMATES & TREND ANALYSIS

4.1. Segment Dashboard
4.2. Monoclonal Antibodies In Veterinary Health Market: Animal Type Movement Analysis, USD Million, 2022 & 2030
4.3. Dogs
  4.3.1. Dogs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Others
  4.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

CHAPTER 5. MONOCLONAL ANTIBODIES IN VETERINARY HEALTH MARKET: APPLICATION ESTIMATES & TREND ANALYSIS

5.1. Segment Dashboard
5.2. Monoclonal Antibodies In Veterinary Health Market: Application Movement Analysis, USD Million, 2022 & 2030
5.3. Dermatology Market
  5.3.1. Dermatology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Pain
  5.4.1. Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Others
  5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

CHAPTER 6. MONOCLONAL ANTIBODIES IN VETERINARY HEALTH MARKET: END-USER ESTIMATES & TREND ANALYSIS

6.1. Monoclonal Antibodies In Veterinary Health Market: End-User Movement Analysis, USD Million, 2022 & 2030
6.2. Veterinary Hospitals
  6.2.1. Veterinary Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Others
  6.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

CHAPTER 7. MONOCLONAL ANTIBODIES IN VETERINARY HEALTH MARKET: REGIONAL ESTIMATES & TREND ANALYSIS

7.1. Monoclonal Antibodies In Veterinary Health Market: Regional Movement Analysis, 2022 & 2030
7.2. North America
  7.2.1. SWOT Analysis
  7.2.2. North America Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.2.3. U.S.
    7.2.3.1. Key Country Dynamics
    7.2.3.2. U.S. Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.2.4. Canada
    7.2.4.1. Key Country Dynamics
    7.2.4.2. Canada Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
  7.3.1. SWOT Analysis
  7.3.2. Europe Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.3.3. UK
    7.3.3.1. Key Country Dynamics
    7.3.3.2. UK Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.3.4. Germany
    7.3.4.1. Key Country Dynamics
    7.3.4.2. Germany Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.3.5. France
    7.3.5.1. Key Country Dynamics
    7.3.5.2. France Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.3.6. Italy
    7.3.6.1. Key Country Dynamics
    7.3.6.2. Italy Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.3.7. Spain
    7.3.7.1. Key Country Dynamics
    7.3.7.2. Spain Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
  7.4.1. SWOT Analysis
  7.4.2. Asia Pacific Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.4.3. China
    7.4.3.1. Key Country Dynamics
    7.4.3.2. China Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.4.4. Japan
    7.4.4.1. Key Country Dynamics
    7.4.4.2. Japan Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.4.5. India
    7.4.5.1. Key Country Dynamics
    7.4.5.2. India Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.4.6. Australia
    7.4.6.1. Key Country Dynamics
    7.4.6.2. Australia Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.4.7. South Korea
    7.4.7.1. Key Country Dynamics
    7.4.7.2. South Korea Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
  7.5.1. SWOT Analysis
  7.5.2. Latin America Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.5.3. Brazil
    7.5.3.1. Key Country Dynamics
    7.5.3.2. Brazil Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.5.4. Mexico
    7.5.4.1. Key Country Dynamics
    7.5.4.2. Mexico Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.5.5. Argentina
    7.5.5.1. Key Country Dynamics
    7.5.5.2. Argentina Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East & Africa
  7.6.1. SWOT Analysis
  7.6.2. Middle East & Africa Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.6.3. South Africa
    7.6.3.1. Key Country Dynamics
    7.6.3.2. South Africa Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.6.4. Saudi Arabia
    7.6.4.1. Key Country Dynamics
    7.6.4.2. Saudi Arabia Monoclonal Antibodies In Veterinary Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)

CHAPTER 8. COMPETITIVE LANDSCAPE

8.1. Market Participation Categorization
8.2. Key Company Profiles
  8.2.1 Zoetis
  8.2.2 Merck & Co, Inc.
  8.2.3 Elanco
  8.2.4 Boehringer Ingelheim GmbH
  8.2.5 Indian Immunologicals Ltd
  8.2.6 Virbac
    8.2.6.1. Participant’s Overview
    8.2.6.2. Product Benchmarking
    8.2.6.3. Financial Performance
    8.2.6.4. Strategy Mapping
8.3. List of Other Players (inclusive of companies with pipeline products)
LIST OF TABLES

Table 1 Global Monoclonal Antibodies in Veterinary Health Market, by Region, 2018 - 2030 (USD Million)
Table 2 North America Monoclonal Antibodies in Veterinary Health Market, By Region, 2018 - 2030 (USD Million)
Table 3 North America Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 4 North America Monoclonal Antibodies In Veterinary Health Market, by Application
Table 5 North America Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 6 US Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 7 US Monoclonal Antibodies In Veterinary Health Market, by Application
Table 8 US Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 9 Canada Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 10 Canada Monoclonal Antibodies In Veterinary Health Market, by Application
Table 11 Canada Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 12 Europe Monoclonal Antibodies in Veterinary Health Market, By Region, 2018 - 2030 (USD Million)
Table 13 Europe Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 14 Europe Monoclonal Antibodies In Veterinary Health Market, by Application
Table 15 Europe Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 16 Germany Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 17 Germany Monoclonal Antibodies In Veterinary Health Market, by Application
Table 18 Germany Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 19 UK Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 20 UK Monoclonal Antibodies In Veterinary Health Market, by Application
Table 21 UK Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 22 Spain Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 23 Spain Monoclonal Antibodies In Veterinary Health Market, by Application
Table 24 Spain Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 25 Italy Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 26 Italy Monoclonal Antibodies In Veterinary Health Market, by Application
Table 27 Italy Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 28 France Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 29 France Monoclonal Antibodies In Veterinary Health Market, by Application
Table 30 France Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 31 Asia Pacific Monoclonal Antibodies in Veterinary Health Market, By Region, 2018 - 2030 (USD Million)
Table 32 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 33 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by Application
Table 34 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 35 Japan Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 36 Japan Monoclonal Antibodies In Veterinary Health Market, by Application
Table 37 Japan Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 38 China Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 39 China Monoclonal Antibodies In Veterinary Health Market, by Application
Table 40 China Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 41 India Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 42 India Monoclonal Antibodies In Veterinary Health Market, by Application
Table 43 India Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 44 Australia Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 45 Australia Monoclonal Antibodies In Veterinary Health Market, by Application
Table 46 Australia Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 47 South Korea Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 48 South Korea Monoclonal Antibodies In Veterinary Health Market, by Application
Table 49 South Korea Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 50 LATAM Monoclonal Antibodies in Veterinary Health Market, By Region, 2018 - 2030 (USD Million)
Table 51 LATAM Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 52 LATAM Monoclonal Antibodies In Veterinary Health Market, by Application
Table 53 LATAM Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 54 Brazil Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 55 Brazil Monoclonal Antibodies In Veterinary Health Market, by Application
Table 56 Brazil Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 57 Mexico Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 58 Mexico Monoclonal Antibodies In Veterinary Health Market, by Application
Table 59 Mexico Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 60 Argentina Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 61 Argentina Monoclonal Antibodies In Veterinary Health Market, by Application
Table 62 Argentina Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 63 MEA Monoclonal Antibodies in Veterinary Health Market, By Region, 2018 - 2030 (USD Million)
Table 64 MEA Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 65 MEA Monoclonal Antibodies In Veterinary Health Market, by Application
Table 66 MEA Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 67 South Africa Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 68 South Africa Monoclonal Antibodies In Veterinary Health Market, by Application
Table 69 South Africa Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 70 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, by Animal Type
Table 71 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, by Application
Table 72 Saudi Arabia Monoclonal Antibodies In Veterinary Health Market, by End-User
Table 73 Participant’s overview
Table 74 Financial performance
Table 75 Product Benchmarking
Table 76 Key companies undergoing strategies
LIST OF FIGURES

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Monoclonal Antibodies in Veterinary Health Market segmentation
Fig. 9 Market driver relevance analysis (Current & future impact)
Fig. 10 Market restraint relevance analysis (Current & future impact)
Fig. 11 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 12 Porter’s five forces analysis
Fig. 13 Ansoff’s matrix analysis
Fig. 14 Heat map analysis
Fig. 15 Market penetration vs growth prospect mapping
Fig. 16 Market share of key market players- Monoclonal Antibodies in Veterinary Health Market
Fig. 17 Strategy mapping
Fig. 18 Monoclonal Antibodies in Veterinary Health Market animal type outlook: 2022
Fig. 19 Monoclonal Antibodies in Veterinary Health Market: animal type movement analysis
Fig. 20 Dogs market, 2018 - 2030 (USD Million)
Fig. 21 Others market, 2018 - 2030 (USD Million)
Fig. 22 Monoclonal Antibodies in Veterinary Health Market application outlook: 2022
Fig. 23 Monoclonal Antibodies in Veterinary Health Market: application movement analysis
Fig. 24 Dermatology market, 2018 - 2030 (USD Million)
Fig. 25 Pain market, 2018 - 2030 (USD Million)
Fig. 26 Others market, 2018 - 2030 (USD Million)
Fig. 27 Monoclonal Antibodies in Veterinary Health Market end-user outlook: 2022
Fig. 28 Monoclonal Antibodies in Veterinary Health Market: end-user movement analysis
Fig. 29 Veterinary Hospitals market, 2018 - 2030 (USD Million)
Fig. 30 Others market, 2018 - 2030 (USD Million)
Fig. 31 Regional marketplace: 2022
Fig. 32 Regional outlook, 2018 & 2030
Fig. 33 North America Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 34 U.S. Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 35 Canada Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 36 Europe Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 37 UK Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 38 Germany Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 39 France Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 40 Italy Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 41 Spain Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 42 Asia Pacific Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 43 Japan Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 44 China Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 45 India Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 46 Australia Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 47 South Korea Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 48 Latin America Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 49 Brazil Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 50 Mexico Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 51 Argentina Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 52 MEA Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 53 South Africa Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 54 Saudi Arabia Monoclonal Antibodies in Veterinary Health Market, 2018 - 2030 (USD Million)
Fig. 55 Strategy framework
Fig. 56 Market participant categorization


More Publications